2,593
Views
6
CrossRef citations to date
0
Altmetric
Special review series

Targeting platelet inhibition receptors for novel therapies: PECAM-1 and G6b-B

ORCID Icon, ORCID Icon & ORCID Icon
Pages 761-769 | Received 03 Aug 2020, Accepted 15 Jan 2021, Published online: 01 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (5)

Natalia Marcińczyk, Tomasz Misztal, Ewa Chabielska & Anna Gromotowicz-Popławska. (2023) Sex-dependent effects of canagliflozin and dapagliflozin on hemostasis in normoglycemic and hyperglycemic mice. Scientific Reports 13:1.
Crossref
Trung Quang Le, Latticha Pluemhathaikij, Katriya Chankow, Araya Radtanakatikanon, Anudep Rungsipipat & Kasem Rattanapinyopituk. (2022) Case report: BCL-2 and CD31 immunoexpression related to clinical and histopathological evaluation of renal dysplasia in a Welsh Corgi Puppy. Frontiers in Veterinary Science 9.
Crossref
Muataz Ali Hamad, Krystin Krauel, Nancy Schanze, Nadine Gauchel, Peter Stachon, Thomas Nuehrenberg, Mark Zurek & Daniel Duerschmied. (2022) Platelet Subtypes in Inflammatory Settings. Frontiers in Cardiovascular Medicine 9.
Crossref
Natalia Marcinczyk, Tomasz Misztal, Anna Gromotowicz-Poplawska, Agnieszka Zebrowska, Tomasz Rusak, Piotr Radziwon & Ewa Chabielska. (2021) Utility of Platelet Endothelial Cell Adhesion Molecule 1 in the Platelet Activity Assessment in Mouse and Human Blood. International Journal of Molecular Sciences 22:17, pages 9611.
Crossref
Loredana Bury, Emanuela Falcinelli, Anna Maria Mezzasoma, Giuseppe Guglielmini, Stefania Momi & Paolo Gresele. (2021) Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway. Haematologica 107:7, pages 1643-1654.
Crossref